DISEASE-SPECIFIC TOPICS

The Top Infectious Disease News Delivered Weekly

Healthcare professionals and thought leaders share their knowledge and insights on an array of infectious disease topics

Latest Videos

What Makes Elizabethkingia Unique?

Emil Lesho, DO, FACP, FIDSA, FSHEA, explains what makes Elizabethkingia unique.

How to Create Institution-Specific Antibiotic Stewardship Interventions

Contagion® Editorial Advisory Board member, James S. Lewis, PharmD, FIDSA, shares how antibiotic stewards can craft stewardship interventions to their own reality.

Fighting Pseudomonas: Impact On Patient Prognosis & Approaches to Combat Infection

Peter L. Salgo, MD; Jason Pogue, PharmD, BCPS-AQID; Andrew Shorr, MD; Marin Hristos Kollef, MD; and Yoav Golan, MD, reflect on the impact that Pseudomonas infections have on patients’ prognoses and outline the basic treatment approaches they take to combat these infections.

Long-Acting Injectable ART: Benefits & Misconceptions

Joseph Eron, MD, discusses benefits of long-acting injectable antiretroviral therapy as well as misconceptions.

MDR Infections: Overview of Antimicrobial Stewardships

Peter L. Salgo, MD; Jason Pogue, PharmD, BCPS-AQID; Debra Goff, PharmD, FCCP; and Sandy J. Estrada Lopez, PharmD, BCPS (AQID), outline the function of antimicrobial stewardships regarding multidrug-resistant bacterial infections and emphasize the importance of personnel at all levels within this system.

Nurses & Disinfection Practices: What Role Do They Play?

Barley Chironda, RPN, CIC, explains the role that nurses play in disinfection practices at health care facilities.

New Treatments on the Horizon for Pseudomonas Infections

Marin H. Kollef, MD, discusses new therapies in development for the treatment of Pseudomonas infections.

Gram-Positive NIs: Costs of Lipoglycopeptide Therapy

Peter L. Salgo, MD; Debra Goff, PharmD, FCCP; Andrew Shorr, MD; Sandy J. Estrada Lopez, PharmD, BCPS (AQID); and Jason Pogue, PharmD, BCPS-AQID, identify the balance that needs to be struck between cost and effectiveness in the context of lipoglycopeptide therapy for gram-positive nosocomial infections.

<< Prev Page

Next Page >>

FEATURED

A Cure for HIV? An Update One Year Later

Big advances in treatment can